Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase Ib/IIa PK/PD and safety study of tianagliflozin tablets in adults with type 2 diabetes mellitus
CTR20201558Phase 2Active
- Sponsor
- Tianjin Institute of Pharmaceutical Research
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tigeliflozin in type 2 diabetes mellitus (T2DM), sponsored by Tianjin Institute of Pharmaceutical Research. Started Aug 2020; status: active.
02
Drugs
tigeliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20201558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201558.